Noridian opens five proposed LCDs for comments through November 14
Oct 11, 2026 edition · GC-2026-0197 · Published 2026-10-11 · Version 3 · Proposed
Noridian invites November 14 comments on five proposed LCDs covering brain MRI analysis, nail surgery, knee injections, and two wound-imaging technologies. The notice identifies a consultation period, rather than effective clinical coverage restrictions.
What happened
The October 1 notice identifies automated brain-MRI detection and quantification, DL40454; surgical treatment of nails, DL40462; knee-osteoarthritis hyaluronic-acid injections, DL40456; bacterial-presence fluorescence wound imaging, DL40441; and near-infrared spectroscopy for wound and flap management, DL40458. The comment period runs October 1 through November 14. Each policy has a separate MCD identifier, so the announcement should not be treated as one combined proposed clinical standard.
The listed contracts include California JE coverage along with Nevada and specified Pacific jurisdictions. Noridian directs readers to the CMS Coverage Database for the proposed documents and asks that comments identify the specific policy, using the proposed-LCD submission guidance for email or mail details. Specialty review should therefore begin with the relevant draft itself and its evidence. This announcement does not reproduce all proposed indications or exclusions, adopt them as final, or establish that current claims must immediately follow the proposed restrictions.
Scope and timing
- Authority status
- Proposed
- Applicability
- Operationally relevant
- Audience
- Health systems, Provider networks
- Jurisdiction
- Federal
- Affected functions
- Revenue Cycle, Compliance, Clinical Operations
- Responsible owner
- Revenue Cycle
- Recorded date
- 2026-11-14
- Date type
- comment
Why it matters
Assess the development with the operational owner before changing applicable policies or payment workflows.
Recommended action
Route the five policy proposals to the affected clinical and billing owners and decide whether to submit evidence before November 14.
Implementation playbook
- Route the five policy proposals to the affected clinical and billing owners and decide whether to submit evidence before November 14. Revenue Cycle · Due 2026-11-14
- Record the applicability assessment and validate the affected workflow with its operational owner. This is an internal review target, not an additional statutory deadline. Compliance · Due 2026-10-12
Sources
- Multiple LCDs, published for review and commentsOfficial · Noridian Medicare · 2026-10-01 · Source review 2026-10-11
Complete edition and supplemental material
This finding in the complete approved report →Regulatory horizons, CIA trends and implementation trackers remain in the full report.
Read the entire Medicare & Medicaid report →